CryoCustom Development
Custom cell cryopreservation protocol development
ServiceActive
Key Facts
About Evia Bio
Evia Bio is a private, pre-revenue biotech tools and services company founded in 2020, specializing in non-DMSO cryopreservation technology for cell therapies. Its core platform, driven by AI and the expertise of founder Dr. Allison Hubel, aims to solve critical bottlenecks in cell therapy manufacturing and storage by replacing toxic preservatives. The company operates through a B2B model, providing products, protocol development, and training services to cell therapy developers, positioning itself as an enabler for the broader oncology and immunology therapeutic sectors.
View full company profile